Abstract:Junfeng Chen, &ast Wei Lin, &ast Haiting Gu, Kangtai Ying, Tingjian Li, Haiyan Shao Department of Respiration, The First People's Hospital of Wenling, Wenling, Zhejiang, 317500, People's Republic of China &astThese authors contributed equally to this work Correspondence: Haiyan Shao, Department of Respiration, The First People's Hospital of Wenling, 333 Chuanan Nan Road, Chengxi Street, Wenling, Zhejiang, 317500, People's Republic of China, Tel +86 057689668688, Email Objective: This study aimed to compare lung function and airway inflammation among cough variant asthma (CVA), chronic cough and classical asthma (CA) and investigate the relationship between these indicators and their possible mechanisms of action in the progression of CVA to CA. Methods: 36 patients with chronic cough, 39 patients with CA, and 57 patients with CVA were included in this study. Pulmonary function tests, bronchial provocation tests and FeNO tests were performed. The patients' bronchoalveolar lavage fluid (BALF) was collected, the cells in BALF were counted, and the levels of Th1 and Th2 cytokines were detected. Results: The neutrophils, lymphocytes, and eosinophils in BALF in the CA and CVA groups were significantly higher than those in the chronic cough group. Also, they were negatively correlated with FEV1, FVC, and FEV1/FVC and positively correlated with IgE and FeNO. The expression of Th2-related cytokines was increased in CVA and CA patients, and it was positively correlated with FEV1, FVC and FEV1/FVC and negatively correlated with IgE and FeNO, while the results of Th1-related cytokines were the opposite of those for Th2-related cytokines. Conclusion: CVA differs from asthma and chronic cough in terms of Th1/Th2 cytokines and lung function and provides a reference for understanding the disease mechanism of early clinical progression of CVA to CA. Keywords: cough variant asthma, cytokines, pulmonary function, Th1/Th2 balance, cell classified count Chronic cough is defined as a disabling complaint affecting 5~10% of the general population, 1 and about 33.3% of chronic cough cases are caused by cough variant asthma (CVA), a specific and atypical asthma phenotype. 2,3 CVA is characterized by an irritating cough at night or early in the morning, which will affect the quality of life of patients. According to a previous study, around 30~40% of CVA patients will develop classic asthma (CA). 4 However, CVA is easily overlooked and misdiagnosed clinically because, unlike CA patients who present with wheezing, its patients present with only cough. More importantly, the mechanism of evolution from CVA to CA has not been fully elucidated. Thus, studying CVA is helpful to better understand the pathogenesis of asthma, improve the quality of life for CVA sufferers, avoid further development of CA, and preserve lung function. The pathogenesis of CVA is the same as that of CA and is mostly associated with chronic inflammation in the airway, often mediated by a variety of inflammatory factors. 3,5 Studies indicated that there is an imbalance of helper T cell 1 (Th1) / Th2 in CAV, which manifests as an immune response dominated by Th2. 6 Th2-related cytokines can induce the release of inflammatory mediators and lead to local airway inflammatory cell infiltration. Th2 cells can secrete various inflammatory factors, including interleukin-4 (IL-4), IL-5, IL-13 and IL-25. 7 This continuous infiltration of inflammatory factors increases airway sensitivity and leads to asthma attacks. Interferon-γ (IFN-γ) is an important cytokine secreted by Th1 cells, which interacts or restricts with Th2-related cytokines in the occurrence and development of asthma to jointly regulate the synthesis and conversion of immunoglobulin E (IgE). 8 Earlier research found that the serum levels of IL-4, IL-5, IL-6 and IL-13 were significantly increased in CVA patients and can be used as an indicator of the extent of the disease. 9 Additionally, CVA patients have less severe airway inflammation than CA patients. 10 Thus, Th1/Th2-associated cytokines have clinical significance in the diagnosis of early CVA and may avoid misdiagnosis and missed diagnosis to better understand the progression of the disease. Taken together, for the diagnosis, treatment, and prognosis of CVA, the level of inflammatory factors in the body of patients is of great relevance. In this study, we detected the classified count of cells and the levels of Th1 and Th2 cytokines in bronchoalveolar lavage fluid (BALF) of patients with a chronic cough in our hospital to investigate the possible mechanisms of these factors in the evolution from CVA to CA and to provide a theoretical basis fo -Abstract Truncated-

The TLR4/NF-κB signaling pathway-mediated type 2 skewing of T helper cell in cough variant asthma was counteracted by ethanol extract of Anacyclus pyrethrum root

Ethanol Extract of Anacyclus pyrethrum Root Ameliorates Cough-Variant Asthma Through the TLR4/NF-κB Pathway and Wnt/β-Catenin Pathway

Airway Inflammation, Bronchial Hyperresponsiveness, and Anti-Asthma Therapy Responses in Cough Variant Asthma and Classic Asthma with FEV1%≥80% Predicted

Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF- κ B Signaling

Activity study of the ethanol extract of thunberg fritillary leaf and the ethanol extract of thunberg fritillary flower on relieving cough, abolishing phlegm and relieving asthma

Amygdalin Attenuates Airway Epithelium Apoptosis, Inflammation, and Epithelial-Mesenchymal Transition through Restraining the TLR4/NF-κB Signaling Pathway on LPS-Treated BEAS-2B Bronchial Epithelial Cells

Comparative Study of Cough Variant Asthma and Cough Reflex Sensitivity

Curative effect of therapy of clearing away heat,moistening lung and controlling cough and its action for correcting unbalance of Th1/Th2 in patients with cough variant asthma

β-Hydroxybutyric acid upregulated by Suhuang antitussive capsule ameliorates cough variant asthma through GSK3β/AMPK-Nrf2 signal axis

Study on the Relationship Between Bronchoalveolar Lavage Fluid Cell Count, Th1/Th2 Cytokines and Pulmonary Function in Patients with Cough Variant Asthma

Comparative Study of Cough Variant Asthma Responsive and Unresponsive to Bronchodilator Treatment

Therapeutic effects and mechanisms study of Hanchuan Zupa Granule in a Guinea pig model of cough variant asthma

Electroacupuncture-induced activation of GABAergic system alleviates airway inflammation in asthma model by suppressing TLR4/MyD88/NF-κB signaling pathway

Emodin Alleviates the Airway Inflammation of Cough Variant Asthma in Mice by Regulating the Notch Pathway

Mechanism of Action of Yin Nourishing and Heat Clearing Prescription in Treating Cough Variant Asthma Based on Network Pharmacology and Molecular Docking Verification

Curcumin Alleviates Airway Inflammation in Cough-Variant Asthmatic Rats by Modulating M1/M2 Macrophage Polarization

Cytokines of Mononuclear Cells in Peripheral Blood of Patients with Cough Variant Asthma

Zi-Su-Zi decoction improves airway hyperresponsiveness in cough-variant asthma rat model through PI3K/AKT1/mTOR, JAK2/STAT3 and HIF-1α/NF-κB signaling pathways

Eucalyptol, limonene and pinene enteric capsules attenuate airway inflammation and obstruction in lipopolysaccharide-induced chronic bronchitis rat model via TLR4 signaling inhibition

Citrus tachibana Leaves Ethanol Extract Alleviates Airway Inflammation by the Modulation of Th1/Th2 Imbalance via Inhibiting NF-κB Signaling and Histamine Secretion in a Mouse Model of Allergic Asthma

A pilot study of differential gene expressions in patients with cough variant asthma and classic bronchial asthma